Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer

ClinicalTrials.gov ID: NCT02200614

Public ClinicalTrials.gov record NCT02200614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multinational, Randomised, Double-blind, Placebo-controlled, Phase III Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer

Study identification

NCT ID
NCT02200614
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
1,509 participants

Conditions and interventions

Interventions

  • Darolutamide (Nubeqa, BAY1841788) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 11, 2014
Primary completion
Sep 2, 2018
Completion
Jun 13, 2021
Last update posted
Jun 27, 2022

2014 – 2021

United States locations

U.S. sites
55
U.S. states
28
U.S. cities
51
Facility City State ZIP Site status
Not listed Homewood Alabama 35209
Not listed Anchorage Alaska 99503
Not listed Tucson Arizona 85704
Not listed Fountain Valley California 92708
Not listed La Jolla California 92093
Not listed Laguna Hills California 92653
Not listed Los Angeles California 90048
Not listed Los Angeles California 90073-1003
Not listed San Diego California 92120
Not listed Whittier California 90603
Not listed Denver Colorado 80211
Not listed Denver Colorado 80220
Not listed Parker Colorado 80134
Not listed Boca Raton Florida 33486
Not listed Orlando Florida 32803
Not listed Port Saint Lucie Florida 34952
Not listed Coeur d'Alene Idaho 83814
Not listed Chicago Illinois 60612
Not listed Evanston Illinois 60201-1613
Not listed Springfield Illinois 62702
Not listed Greenwood Indiana 46143
Not listed Indianapolis Indiana 46202
Not listed Jeffersonville Indiana 47130
Not listed West Des Moines Iowa 50266
Not listed Wichita Kansas 67226
Not listed New Orleans Louisiana 70121
Not listed Annapolis Maryland 21401
Not listed Baltimore Maryland 21204
Not listed Salisbury Maryland 21801
Not listed Boston Massachusetts 02114
Not listed Grand Rapids Michigan 49546
Not listed Royal Oak Michigan 48073
Not listed Omaha Nebraska 68114
Not listed Omaha Nebraska 68130
Not listed Lebanon New Hampshire 03756-1000
Not listed Voorhees Township New Jersey 08043
Not listed Syracuse New York 13210
Not listed The Bronx New York 10461
Not listed The Bronx New York 10469
Not listed Asheboro North Carolina 27203
Not listed Charlotte North Carolina 28277
Not listed Canton Ohio 44718
Not listed Cincinnati Ohio 45212
Not listed Cleveland Ohio 44195
Not listed Gahanna Ohio 43230
Not listed Middleburg Heights Ohio 44130
Not listed Oklahoma City Oklahoma 73104
Not listed Bala-Cynwyd Pennsylvania 19004
Not listed Myrtle Beach South Carolina 29572
Not listed Nashville Tennessee 37209
Not listed Dallas Texas 75231
Not listed Fairfax Virginia 22031
Not listed Richmond Virginia 23235
Not listed Virginia Beach Virginia 23462
Not listed Wheeling West Virginia 26003

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 349 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02200614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 27, 2022 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02200614 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →